These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36263615)

  • 1. Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.
    Tan J; Ge Y; Martinez L; Sun J; Li C; Westbrook A; Chen E; Pan J; Li Y; Cheng W; Ling F; Chen Z; Shen Y; Huang H
    Epidemiol Infect; 2022 Sep; 150():e171. PubMed ID: 36263615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Proportion of Asymptomatic COVID-19 Cases in an Italian Region with Intermediate Incidence during the First Pandemic Wave: An Observational Retrospective Study.
    Martinelli D; Fortunato F; Mazzilli S; Bisceglia L; Lopalco PL; Prato R
    Biomed Res Int; 2022; 2022():3401566. PubMed ID: 35005026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.
    Nakajo K; Nishiura H
    Theor Biol Med Model; 2021 Jul; 18(1):12. PubMed ID: 34271962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity.
    Subramanian R; He Q; Pascual M
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33571106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China.
    Lao X; Luo L; Lei Z; Fang T; Chen Y; Liu Y; Ding K; Zhang D; Wang R; Zhao Z; Rui J; Zhu Y; Xu J; Wang Y; Yang M; Yi B; Chen T
    Sci Rep; 2021 May; 11(1):9545. PubMed ID: 33953243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmissibility of asymptomatic COVID-19: Data from Japanese clusters.
    Nakajo K; Nishiura H
    Int J Infect Dis; 2021 Apr; 105():236-238. PubMed ID: 33618004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological study design of asymptomatic infection of the 2019 novel coronavirus].
    He N; Lu YH; Li LM; Shen HB; Yang WZ; Feng ZJ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1577-1581. PubMed ID: 32736419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Transmissibility of Coronavirus Between Symptomatic and Asymptomatic Patients: Reanalysis of the Ningbo COVID-19 Data.
    Yin G; Jin H
    JMIR Public Health Surveill; 2020 May; 6(2):e19464. PubMed ID: 32442131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics.
    Harris JD; Park SW; Dushoff J; Weitz JS
    Epidemics; 2023 Mar; 42():100664. PubMed ID: 36706626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study.
    Lovell-Read FA; Funk S; Obolski U; Donnelly CA; Thompson RN
    J R Soc Interface; 2021 May; 18(178):20201014. PubMed ID: 34006127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative transmissibility of asymptomatic COVID-19 infections among close contacts.
    He D; Zhao S; Lin Q; Zhuang Z; Cao P; Wang MH; Yang L
    Int J Infect Dis; 2020 May; 94():145-147. PubMed ID: 32315808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmissibility and pathogenicity of the severe acute respiratory syndrome coronavirus 2: A systematic review and meta-analysis of secondary attack rate and asymptomatic infection.
    Shi N; Huang J; Ai J; Wang Q; Cui T; Yang L; Ji H; Bao C; Jin H
    J Infect Public Health; 2022 Mar; 15(3):297-306. PubMed ID: 35123279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related model for estimating the symptomatic and asymptomatic transmissibility of COVID-19 patients.
    Tan J; Shen Y; Ge Y; Martinez L; Huang H
    Biometrics; 2023 Sep; 79(3):2525-2536. PubMed ID: 36517992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing required SARS-CoV-2 blanket testing rates for possible control of the outbreak in the epicentre Lusaka province of Zambia with consideration for asymptomatic individuals: A simple mathematical modelling study.
    Sichone J; Sinkala M; Munsaka S; Kikonko M; Simuunza M
    PLoS One; 2021; 16(4):e0249479. PubMed ID: 33822785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March-June 2020: Epidemiological Implications.
    Cruz-Rodríguez E; Baldoquín-Rodríguez W; Molina-Águila N; Galindo-Santana BM; Romero-Placeres M; González-Gross TM; Morgado-Vega I; Olivera-Nodarse Y; Guadalupe-Guzmán M
    MEDICC Rev; 2022 Jan; 24(1):21-27. PubMed ID: 35157635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.